Literature DB >> 17098346

Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E.

Aylin Gürbay1, Brigitte Gonthier, Luc Barret, Alain Favier, Filiz Hincal.   

Abstract

The aim of this study was to investigate the possible cytotoxic and oxidative stress inducing effects of ciprofloxacin (CPFX) on primary cultures of rat astrocytes. The cultured cells were incubated with various concentrations of CPFX (0.5-300mg/l), and cytotoxicity was determined by neutral red (NR) and MTT assays. Survival profile of cells was biphasic in NR assay: CPFX did not cause any alteration at any concentration for 7h, whereas < or =50mg/l concentrations induced significant cell proliferation in incubation periods of 24, 48, 72, and 96h. However, cell proliferation gradually decreased at higher concentrations, and 200 and 300mg/l of CPFX exposure was found to be significantly (p<0.05) cytotoxic at all time periods. With MTT assay, no alteration was noted for incubation period of 7h, as observed with NR assay. But, cell viability decreased with approximately > or =50mg/l CPFX exposure in all other time periods. Cell proliferation was only seen in 24h of incubation with 0.5 and 5mg/l CPFX. Vitamin E pretreatment of cell cultures were found to be providing complete protection against cytotoxicity of 300mg/l CPFX in 96h incubation when measured with both NR and MTT assays. The SOD pretreatment was partially protective with NR assay, but no protection was noted when measured with MTT. A significant enhancement of lipid peroxidation was observed with the cytotoxic concentration of the drug, but total glutathione content and catalase activity of cells did not change. The data obtained in this study suggest that, in accordance with our previous results with fibroblast cells, CPFX-induced cytotoxicity is related to oxidative stress. And the biphasic effect of CPFX possibly resulted from the complex dose-dependent relationships between reactive oxygen species, cell proliferation, and cell viability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098346     DOI: 10.1016/j.tox.2006.09.016

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

1.  Evaluation of the Cytotoxicity of Levodopa and its Complex with Hydroxypropyl-ß-Cyclodextrin (HP-ß-CD) to an Astrocyte Cell Line.

Authors:  Zarif Mohamed Sofian; Shazrin Shazira Shafee; Jafri Malin Abdullah; Hasnah Osman; Shariza Abdul Razak
Journal:  Malays J Med Sci       Date:  2014-12

2.  PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experience.

Authors:  Vahid Molla Kazemiha; Mohammad Ali Shokrgozar; Mohammad Reza Arabestani; Morteza Shojaei Moghadam; Shahram Azari; Susan Maleki; Amir Amanzadeh; Mahmood Jeddi Tehrani; Fazel Shokri
Journal:  Cytotechnology       Date:  2010-02-06       Impact factor: 2.058

3.  Ciprofloxacin-collagen conjugate in the wound healing treatment.

Authors:  Francesco Puoci; Cristiana Piangiolino; Francesco Givigliano; Ortensia Ilaria Parisi; Roberta Cassano; Sonia Trombino; Manuela Curcio; Francesca Iemma; Giuseppe Cirillo; Umile Gianfranco Spizzirri; Donatella Restuccia; Rita Muzzalupo; Nevio Picci
Journal:  J Funct Biomater       Date:  2012-05-15

4.  Extracellular Caspase-8 Dependent Apoptosis on HeLa Cancer Cells and MRC-5 Normal Cells by ICD-85 (Venom Derived Peptides).

Authors:  Abbas Zare-Mirakabadi; Ali Sarzaeem
Journal:  Iran J Cancer Prev       Date:  2012

5.  Necrotic Effect versus Apoptotic Nature of Camptothecin in Human Cervical Cancer Cells.

Authors:  Abbas Zare-Mirakabadi; Ali Sarzaeem; Saeed Moradhaseli; Aida Sayad; Masoud Negahdary
Journal:  Iran J Cancer Prev       Date:  2012

6.  Time- and concentration-dependent cytotoxicity of antibiotics used in endodontic therapy.

Authors:  Marina Beloti Ferreira; Suely Myiagi; Carlos Goes Nogales; Marcia Sampaio Campos; José Luiz Lage-Marques
Journal:  J Appl Oral Sci       Date:  2010 May-Jun       Impact factor: 2.698

7.  Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC.

Authors:  Tomasz Kloskowski; Natalia Gurtowska; Joanna Olkowska; Jakub Marcin Nowak; Jan Adamowicz; Jakub Tworkiewicz; Robert Dębski; Alina Grzanka; Tomasz Drewa
Journal:  Int J Oncol       Date:  2012-10-04       Impact factor: 5.650

8.  Novel Segmented Concentration Addition Method to Predict Mixture Hormesis of Chlortetracycline Hydrochloride and Oxytetracycline Hydrochloride to Aliivibrio fischeri.

Authors:  Huilin Ge; Min Zhou; Daizhu Lv; Mingyue Wang; Defang Xie; Xinfeng Yang; Cunzhu Dong; Shuhuai Li; Peng Lin
Journal:  Int J Mol Sci       Date:  2020-01-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.